Antidiabetic drug causes double the weight loss of competitor in Type 2 diabetes patients
(University at Buffalo) Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | International Medicine & Public Health | SGLT2 Inhibitors | Study | Weight Loss